A. Takase

Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing tedizolid and linezolid.

S. Fujimi, H. Mikamo, S. Kusachi, 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study

N. Hayashi, T. Takehara, A. Howe, 2015, Journal of Gastroenterology.

Alteration of Acetaminophen-induced Cytotoxicity in Mouse Hepatocytes during Primary Culture

T. Sakuma, Atika Jaruchotikamol, N. Nemoto, 2009 .

HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials.

D. Nickle, N. Hayashi, A. Howe, 2016, Antiviral research.

Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells

A. Tomoda, M. Naito, M. Inazu, 2011, International journal of oncology.

[Pharmacological action and clinical effect of tedizolid phosphate (SIVEXTRO® Tablets 200 mg, for iv infusion 200 mg), a novel oxazolidinone-class antibacterial drug].

M. Mori, A. Takase, 2020, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

The safety and efficacy of relebactam/imipenem/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection: A multicenter, open-label, noncomparative phase 3 study.

S. Kohno, M. Brown, Amanda Paschke, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.